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Summary Information on 23,567 Non-Hispanic White, 2,539 Black, and 2,380 Hispanic breast cancer cases
diagnosed between 1977 and 1985 was used to evaluate the risk of late stage diagnosis and long duration of
symptoms prior to diagnosis in relation to ethnicity, socioeconomic status, age and year of diagnosis. All data
were collected by the University of Southern California Cancer Surveillance Program, the comprehensive
population-based incidence registry of Los Angeles County. The results indicate that lower socioeconomic
status, Black or Hispanic ethnicity, younger age, and earlier year of diagnosis are risk factors for late stage
diagnosis and long duration of symptoms. The effect ofethnicity was not explained by lower SES levels among
Black or Hispanic women. After controlling for duration of symptoms, race and SES remained significantly
predictive of more advanced stage. More recent diagnosis across the 9 year time frame was not associated with
improved stage for those of low SES. These results suggest that increased efforts are needed to reach low SES
and Black and Hispanic women with campaigns to improve the stage at which breast cancer is detected.
Numerous studies have shown that breast cancer survival
rates are lower among Black than White women (Axtell &
Meyers, 1978; Ernster et al., 1978; Nemoto et al., 1980; Ries
et al., 1983; Young et al., 1984; Vernon et al., 1985) and
among those of lower socioeconomic status (SES) than those
of higher SES (Ernster et al., 1978; Linden, 1969; Lipworth
et al., 1970; Berg et al., 1977; Dayal et al., 1982; Chirikos et
al., 1984). Black women (Axtell & Meyers, 1978; Bain et al.,
1986; Polednak, 1986) as compared to White women, and
poorer women as compared to wealthier women (Farley &
Flannery, 1989) are diagnosed with later stage breast cancer
and report longer delays in responding to symptoms of
cancer. Although the poorer survival of Black vs White
women is present at each stage of disease, the magnitude of
the Black-White difference increases as stage increases
(Baquet et al., 1986). There are relatively few studies that
have compared Hispanic women with other ethnic groups,
but Hispanic women also appear to be diagnosed with more
advanced breast cancer than non-Hispanic Whites (West-
brook et al., 1975; Horm, 1987; Samet et al., 1988).
Differences in stage at diagnosis across racial-ethnic groups
may be explained by differences in the distribution of SES. It
is not clear whether lower SES Black or Hispanic patients
experience later stage of diagnosis than non-Hispanic White
patients of comparable SES (Polednak, 1986; Page & Kuntz,
1980; Gregorio et al., 1983; Saunders, 1989). If the effect of
race-ethnicity on stage is primarily due to SES, there should
be no differences between racial-ethnic groups when SES is
held constant. A difference in delay patterns among racial-
ethnic groups and/or SES strata, may reflect less knowledge
about cancer symptoms (Horm, 1987; Denniston, 1985;
Michielutte & Diesker, 1982; Coreil, 1984), poorer access to
care or routine screening (McWhorter & Mayer, 1987) or
greater pessimism about the successful treatment of cancer
(Michielutte & Diesker, 1982). Delay between the time when
symptoms are first noted and actual diagnosis may also be
due to delays in the health care system which may also be
related to SES or racial-ethnic differences among patients.
Differences in stage at diagnosis among racial-ethnic
groups or SES levels may be related to delay patterns. Alter-
natively, advanced stage at diagnosis may reflect underlying
differences in the biological behaviour of breast tumours
among racial-ethnic groups or women of different socio-
economic background. There is some indication that Black
women are more likely to have aggressive disease. Owenby et
al. (1985) found a higher rate of poorly differentiated and
fast growing tumours in Black patients. Women with faster
growing tumours would be expected to have more advanced
disease at diagnosis even if delay is short. It is reasonable to
expect delay to be highly predictive of stage, yet it is impor-
tant to determine whether more advanced stage is fully
explained by delay patterns or whether SES or race-ethnicity
have an independent effect.
Finally, both delay and extent of disease at diagnosis may
be related to age (Goodwin et al., 1986) or to changes in
detection strategies over time. Any age or calendar year
effects may operate differently among different racial-ethnic
groups or SES levels. A recent study in Detroit indicated that
over the 10 year period, 1978-1987, both Black and White
women were more likely to be diagnosed with smaller
tumours in the more recent years (Swanson et al., 1990).
This paper examines the relationships of stage at breast
cancer diagnosis and delay in diagnosis with SES, race-
ethnicity, age, and year of diagnosis using data on women
aged 40 and older collected by the Cancer Surveillance Pro-
gram, the population-based cancer registry of Los Angeles
County.
Methods
The Cancer Surveillance Program (CSP) is a comprehensive,
population-based cancer registry that has collected incidence
data since 1972 on the now more than 8.8 million residents
of Los Angeles County (Hisserich et al., 1975; Mack, 1977).
The method of case identification has been described
elsewhere (Mack, 1977). We describe here data collected from
1977 through 1985. During that period, each case was char-
acterised by age, sex, race-ethnicity, census tract of residence,
stage of tumour, date of diagnosis and duration of symptoms
before first diagnosis (i.e. delay in diagnosis). The data were
abstracted by trained medical record technicians from hos-
pital admission sheets and from medical records. All White
cases were classified either as Hispanic, on the basis of
Spanish surname, or Non-Hispanic (without Spanish sur-
name) using a modification of the 1970 US Census Bureau
detailed Spanish surname list. Women with unknown race or
age were eliminated. Social class has been assigned not on an
individual basis, but on a geographic basis according to the
census tract of residence at the time of diagnosis. An SES
index from 1 (high) through 5 (low) has been assisgned to
each census tract based on the median educational level and
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median family income level of inhabitants from the 1970
census using a modification of the Hollingshead Index (Holl-
ingshead & Redlich, 1958). The census tract index score was
assigned to each individual in that census tract. Census tract
aggregates thus provide information about social class of the
County population.
The analyses reported here are limited to non-Hispanic
Whites, Hispanic White, and Blacks diagnosed with breast
cancer between 1977 and 1985. Data accrued prior to 1977
and after 1985, were not used in these analyses because
duration of symptoms was not routinely recorded on the
CSP abstract form prior to 1977 or after 1985. The high and
medium-high SES levels were combined into one group
because there were small numbers of Hispanic or Black cases
in the highest SES group. Cases were categorised into four
age groups, 40-49, 50-59, 60-69, and 70 years or older.
The 9 years examined were divided into 3-year strata. Cases
with unknown SES classification (1.4%) unknown stage
(4.5%) and unknown duration of symptoms (19.3%) were
excluded from analyses that included these variables. The
percentages of cases across the three time intervals with
missing information on duration of symptoms increased from
15.9% in 1977-79, to 18.7% in 1980-82, to 22.7% in
1983-85, but were approximately equivalent for stage during
these periods (4.1%, 4.6%, and 4.8% respectively). The
percentage of reports missing stage or delay information was
not markedly different among SES strata or racial-ethnic
groups.
Odds ratios (OR) were computed for the risk of nonlocal
(direct extension, regional nodes, distant metastasis, nonlocal
but not otherwise specified) vs localised (in situ, localised-
confined to organ of origin) stage at breast cancer diagnosis
and for longer (>lmonth) vs shorter ((< 1 month) duration
of symptoms by racial-ethnic group, SES, age, and year of
diagnosis. Ninety-five percent confidence limits (95% CI) for
the odds ratios were computed by Cornfield's method. For
adjusted analyses, the Mantel-Haenszel estimate of the odds
ratio was computed and continuity-corrected tests of trend
using Mantel's method were used (Breslow & Day, 1980).
Multivariate logistic regression models evaluating the rela-
tionship between duration of symptoms and stage at diag-
nosis for SES and race-ethnicity groups were assessed. All
P-values presented are two-sided.
Results
The number of cases of breast cancer by racial-ethnic group
and by SES are provided in Table I for all years of diagnosis
and all ages combined. The percentages of Black (25.1%)
and Hispanic (19.5%) cases classified as low SES are sub-
stantially greater than the percentage of non-Hispanic White
cases (4.1%). Nonlocal stage of disease occurred among
50.5% of Hispanics, 50.0% of Blacks, and 43.6% of non-
Hispanic White. Symptoms were present for more than one
month's duration prior to diagnosis for 54.4% of Hispanics,
54.6% of Blacks, and 40.5% of non-Hispanic Whites.
At the time of diagnosis, 18.5% of non-Hispanic Whites,
12.5% of Blacks, and 12.4% of Hispanic women (17.5% of
all women) reported that they had no symptoms (these were
all classified as less than one month's duration) (Table I).
Sixty-six percent of those with symptoms reported a mass
(lump) as the first symptom. For those who had a mass as
the presenting symptom, 44.0% of non-Hispanic Whites,
55.9% of Blacks, and 56.8% of Hispanics were diagnosed
after the symptoms persisted for at least one month. One
percent of all women reported bleeding as the first symptom,
8% reported other symptoms and 8% were missing this
information. The percentage of women reporting no symp-
toms at diagnosis increased over time for all racial-ethnic
groups and for all age groups.
The effects of age, race-ethnicity, SES, and year of diag-
nosis on risk of late stage of disease are presented in Table
II. Older age was found to be associated with earlier stage
(trend P<0.001), however, the effect was small and inconsis-
tent at younger ages. Black and Hispanic women were at
greater risk of late-stage disease (OR= 1.29; P<0.001;
OR = 1.32, P<0.001) than non-Hispanic Whites. Risk levels
for stage among Hispanics were comparable to those of
Blacks. Risk of late stage disease increased with declining
SES (trend P<0.001). In more recent years a slightly greater
proportion (approximately 10%) of patients had localised
disease at diagnosis (trend P = 0.002). In multivariate models
which included SES, race-ethnicity, year, and age, the
adjusted odds ratios were virtually identical for age and year
but were somewhat diminished for SES and ethnicity. Never-
theless, both SES and ethnicity remained statistically
significant predictors of stage at diagnosis.
The effects of age, race-ethnicity, SES, and year of diag-
nosis on risk of long duration of symptoms at diagnosis are
presented in Table III. Older age was found to be associated
with shorter duration of symptoms (trend P<0.001) but,
unlike the trend for stage, the trend for duration consistently
decreased for all ethnic groups as age increased. As com-
pared to non-Hispanic Whites, Blacks were at greater risk of
long duration of symptoms (OR = 1.75, P<0.001) as were
Hispanics (OR = 1.77, P<0.001). Risk of long duration of
symptoms increased with declining SES (trend P<0.001). In
more recent years a slightly greater proportion (approx-
imately 15%) of patients had shorter duration of symptoms
(trend P<0.001). The adjusted odds ratios were virtually
identical for age and year but were somewhat diminished for
Table I Frequency of female breast cancer cases in racial-ethnic groups by SES,
duration, stage, and presenting symptoms in women > 40 yrs Los Angeles County,
1977-1985
Hispanic Black Non-Hispanic White
No. % No. % No. %
SES
High/Medium High 418 (17.8) 237 (9.5) 9745 (41.8)
Medium 505 (21.4) 312 (12.5) 6225 (26.7)
Medium Low 974 (41.3) 1323 (52.9) 6392 (27.4)
Low 459 (19.5) 628 (25.1) 965 (4.1)
Duration of symptoms
< I Month 893 (45.6) 915 (45.4) 11367 (59.5)
>1 Month 1065 (54.4) 1102 (54.6) 7731 (40.5)
Stage at diagnosis
Local 1140 (49.5) 1213 (50.0) 12738 (56.4)
Nonlocal 1163 (50.5) 1209 (50.0) 9830 (43.6)
Symptoms
None 295 (12.4) 318 (12.5) 4369 (18.5)
Mass/Lump 1719 (72.2) 1751 (69.0) 15253 (64.7)
Bleeding 28 (1.2) 39 (1.5) 236 (1.0)
Other 153 (6.4) 216 (8.5) 1863 (8.0)
Unknown 185 (7.8) 215 (8.5) 1846 (7.8)924 J.L. RICHARDSON et al.
Table II Risk of late stage diagnosis of breast cancer
Crude Odds Ratios Adjusted Odds Ratiosa
No. cases
Local Nonlocal OR 95% CI OR 95% CI
Age
40-49 2498 2030 1.0 1.0
50-59 3553 3254 1.13b (1.04-1.22) 1.13b (1.05-1.27)
60-69 4093 3321 1.00 (0.93-1.08) 1.01 (0.94-1.09)
70 + 4947 3597 0.89b (0.83-0.96) 0.90b (0.83-0.97)
Trend P-value P<0.001 P<0.001
Race-ethnicity
Non-Hispanic White 12738 9830 1.0 1.0
Black 1213 1209 1.29b (1.19-1.41) 1.17b (1.07-1.28)
Hispanic 1140 1163 1.32b (1.21-1.44) 1.22b (1.12-1.34)
SES
High/Medium/High 5818 4256 1.0 1.0
Medium 3766 3014 1.09b (1.03-1.17) 1.job (1.03-1.17)
Medium/Low 4473 3870 1.21b (1.12-1.25) 1.16b (1.09-1.23)
Low 961 1006 1.43b (1.30-1.58) 1.35b (1.21-1.49)
Trend P-value P<0.001 P<0.001
Calendar period
1977-79 4657 3936 1.0 1.0
1980-82 4854 4005 0.98 (0.92-1.04) 0.97 (0.92-1.03)
1983-85 5580 4261 090b (0.85-0.96) 0-91b (0.86-0.97)
Trend P-value P<0.002 P<0.001
aAdjusted for other factors shown in table. bSignificant at P<0.05. OR = Odds ratio, 95%
CI = 95% Confidence Interval.
Table III Risk of duration of symptoms over one month
Crude Odds Ratios Adjusted Odds Ratiosa
No. cases
I JMonth >I Month OR 95% CI OR 95% C
Age
40-49 1828 1929 1.0 1.0
50-59 3273 2537 0.73b (0.68-0.80) 0.75b (0.69-0.82)
60-69 3705 2599 0.66b (0.61-0.72) 0.69b (0.63-0.75)
70 + 4369 2833 0.61b (0.57-0.67) 0.63b (0.58-0.68)
Trend P-value P<0.001 P<0.001
Race-ethnicity
Non-Hispanic White 11367 7731 1.0 1.0
Black 915 1102 1.75b (1.60-1.93) 1.50b (1.36-1.66)
Hispanic 893 1065 1.77b (1.61 -1.94) 1.52b (1.37-1.67)
SES
High/Medium/High 5203 3344 1.0 1.0
Medium 3335 2405 1.12b (1.05-1.20) 1.13b (1.05-1.21)
Medium/Low 3849 3241 1.31b (1.23-1.40) 1.24b (1.16-1.33)
Low 764 891 1.81b (1.63-2.02) 1.56b (1.39-1.75)
Trend P-value P<0.001 P<0.001
Calendar period
1977-79 4205 3333 1.0 1.0
1980-82 4181 3355 1.01 (0.95-1.08) 1.00 (0.94-1.07)
1983-85 4789 3210 0.85b (0.79-0.90) 0.84b (0.79-0.90)
Trend P-value P<0.002 P<0.001
aAdjusted forotherfactors shown in table. bSignificant atP<0.05. OR = Oddsratio, 95%CI = 95%
Confidence Interval. Each adjusted odds ratio adjusts for all other main effects.
SES and ethnicity. As above, both race-ethnicity and SES
remained statistically significant predictors of long duration
of symptoms.
We examined calendar effects to determine whether earlier
stage and shorter duration of symptoms in more recent years
were occurring uniformly among different ethnic groups, age
groups and SES levels. For non-Hispanic White women, risk
of late stage disease declined over the time period studied
from 1977-79 to 1983-85 for younger (trend P = 0.04) and
older women (trend P = 0.02), however, when stratified by SES level, the decline was statistically significant only for
high/medium high SES women (trend P = 0.002) for younger and P = 0.02 for older women). In fact, for low SES non-
Hispanic Whites, the trend actually was reversed, although
not significant. There was no significant calendar year trend
in the risk of late stage diagnosis for older or younger Hispanic women within any SES level or after adjustment for
SES and age. Black women, like non-Hispanic White women,
showed a significant decline in risk of late stage disease over
time after adjustment for age and SES (trend P = 0.02 for
younger and trend P = 0.04 for older women) and the pat-
tern was the same within SES strata, although the cell sizes
were too small to be significant. The findings for duration of
symptoms over the calendar periods studied were very similar
to those for stage of disease.
SES andethnicity effects
Further logistic regression analyses were conducted to test
for all possible interactions after controlling simultaneously
for all main effects (age, year, SES, and ethnicity). The
interaction between SES and race-ethnicity for later stage
(Chi-square = 15.0, d.f. = 6, P = 0.02) and for longer dura-
tion ofsymptoms (Chi-square = 14.1, d.f. = 6, P = 0.03) were
statistically significant. The odds ratios for the interaction
between race-ethnicity and SES for the risk of long durationSTAGE OF BREAST CANCER DIAGNOSIS 925
of symptoms (Model 1) and more advanced stage at diag-
nosis (Model 2) adjusted for age and year of diagnosis are
presented in Table IV. Using non-Hispanic White women of
high and medium-high SES as the reference category, it is
apparent that there is an increasing trend in risk of long
duration of symptoms with decreasing SES among all ethnic
groups (Model 1). There is an increasing trend in risk of late
stage diagnosis with decreasing SES among non-Hispanic
White and among Hispanic patients but not among Black
patients (Model 2). Within SES levels, there appears to be an
increased risk of Black and Hispanic women relative to
non-Hispanic White women for both long duration of symp-
toms and stage.
Relationship between duration ofsymptoms and stage at
diagnosis
We further examined the predictive value of duration of
symptoms for extent of disease. Those who experienced
symptoms for longer than 1 month were more likely to be
diagnosed with late stage disease (OR= 1.96, 95% CI =
1.86-2.07) whether they were Hispanic (OR = 1.83, 95%
CI = 1.53-2.19), Black (OR = 2.03, 95% CI = 1.69-4.23) or
non-Hispanic White (OR = 1.94, 95% CI = 1.83-2.06). After
controlling for duration of symptoms, however, race and SES
remained significantly predictive of greater extent of disease
(Model 3); in fact, the odds ratios decreased only slightly
from Model 2 which did not control for duration. After
controlling for race-ethnicity and SES, duration of symptoms
remained related to stage (OR = 1.91, 95% CI = 1.81-2.02).
We further examined very long duration of symptoms
prior to diagnosis. Fewer non-Hispanic White women had
symptoms for over 6 months (13.9%) than either Hispanic
(18.6%) or Black women (19.5%). However, if only those
who have symptoms for over 6 months are examined, 66.7%
of Hispanic women, 68.0% of Black women and 61.0% of
non-Hispanic White women had nonlocal disease indicating
that the disadvantage for minority women persists in this
subcategory.
Discussion
The Cancer Surveillance registry provides data concerning
thousands of cancer cases among diverse SES and ethnic
groups; however, since there is no direct patient contact,
there are certain limitations inherent in these data including
the reliance on Spanish surname to classify Hispanics and the
use of a geographic indicator based on census tract to
categorise SES. Surname is used as an indicator of Hispanic
ethnicity because it is available on health records and is
relatively simple and straightforward to apply as opposed to
other measures such as use of the Spanish language or
having Spanish surname grandparents (Hazuda et al., 1986).
Any classification scheme will give slightly different results
however, ethnic or socioeconomic misclassification, when it
occurs it would cause a bias toward finding no difference
thus our results would be conservative. The data concerning
income are consistent with expectations about proportions of
ethnic groups expected to be at high or low levels derived
from individual data on the census. With regard to
household income by race, Blacks have the lowest household
income levels while Hispanics have the next lowest, on the
other hand, Hispanics have the lowest level of educational
attainment (US Department of Labor, 1980). The SES
indicator is based on census tract income and education as
used in other similar studies (Dayal et at., 1982). The fact
that it produces reasonable results with regard to stage and
delay suggests that it is a good surrogate for individual data.
Determination of stage of disease depends to some extent
on the quality of the medical work-up. More distant but less
overt disease would be classified as local in a less careful
work-up. If the quality of the staging work-up is related to
minority race or lower socioeconomic status we would expect
more patients in these groups to be categorised as local stage
Table IV Risk of long duration of symptoms and of late stage
diagnosis by race/ethnicity and socioeconomic status (adjusted for age
and calendar period)
Model I Model 2 Model 3
OR OR OR
Non-Hispanic White
High/Med High 1.0 1.0 1.0
Medium 1.14a 1.lOa 1.08a
Medium Low 1.22a 1.16a 1.14a
Low 1.44a 1.22a 1.17a
Trend test P<0.001 P<0.001 P<.001
Black
High/Med High 1.65a 1.44a l.36a
Medium 1.25 1.26 1.24
Medium Low 1.84a 1.24a 1.15a
Low 2.63 1.77 1.59a
Trend test P<0.001 P<0.07 P<0.21
Hispanic
High/Med High 1.25a 0.99 0.96
Medium 1.68a l.3la 1.23a
Medium Low 2.04a 1.52a l.39a
Low 2.35a l.72a l.55a
Trend test P<0.001 P<0.001 P<0.001
Symptom duration
(1 month 1.00
>1 month 1.91a
Unknown 1.16a
Model 1: Odds Ratios for longer duration ofsymptoms as related to
SES and ethnicity; Model 2: Odds Ratios for later stage atdiagnosis as
related to SES and ethnicity; Model 3: Odds Ratios for later stage at
diagnosis as related to SES, ethnicity, and duration of symptoms;
aSignificant at P<0.05; OR = Odds ratio.
who were actually non-local. If this bias occurs, our data
would present a conservative estimate of the effects of race
and SES on non-local stage.
These data suggest that more attention needs to be given
to women of low socioeconomic status and to women of
Black and Hispanic ethnicity to improve stage at diagnosis.
Consistent with other studies, low SES and minority race-
ethnicity (Hispanic or Black) are important risk factors for
late stage diagnosis of breast cancer and for long duration of
symptoms (Axtell et al., 1976; Vernon et al., 1985; Polednak,
1985; Saunders, 1989). The disadvantages for Black and His-
panic women in stage at diagnosis and long duration of
symptoms were not 'explained' by differences in SES as
might have been postulated. In each case, there was a statis-
tically significant interaction between SES and race-ethnicity
after adjusting for age and calendar year. Thus the risk of
late stage diagnosis for Black and Hispanic women seems
tobe compounded by poverty. However, upper SES Hispanic
women seem to be much like non-Hispanic White women,
while Black women continue to be at risk of late stage
diagnosis.
Advanced stage at presentation may be due, in part, to
delays in responding to breast symptoms which may differ
between racial-ethnic and SES groups because of differences
in access to care. This is suggested by the observation that
risk of late stage disease in Blacks and Hispanics and in
those of low SES remained significantly elevated after adjust-
ing for duration of symptoms. Among subjects who
experienced at least 6 months duration of symptoms prior to
diagnosis, the disadvantage for minority women persists. The
possibility of biological differences in rates of tumour growth
between races, or SES groups, cannot be ruled out as part of
the reason for advanced stage at presentation. Nevertheless
duration of symptoms is the strongest predictor of stage in
this study, thus behavioural changes resulting in less delay
would be expected to have a major impact on the incidence
of late stage diagnosis. Previous studies have shown that
delay is related to survival, therefore, reducing delay should
result in improvements especially for minority women (Wil-
kinson et al., 1979; Vernon et al., 1985).
The proportion of cases presenting with no symptoms was
higher among Whites in this study which may indicate926 J.L. RICHARDSON et al.
differences among racial-ethnic groups in regular physician
visits or the utilisation of cancer screening methods. Except
for younger low SES women, the proportion of patients
reporting no symptoms prior to diagnosis increased over time
possibly indicating an increased use of mammograms or
other screening tools.
The calendar trend indicates that in recent years women
are somewhat less likely to be diagnosed at a later stage or to
have longstanding symptoms before diagnosis and confirms
data from another recent study (Swanson et al., 1990). While
this is clearly welcome news, stratified analyses indicated that
these improvements do not occur among lower SES women.
Whether the long delays in lower SES patients is due to the
behaviour ofthe patients themselves or to reduced access and
delivery of health care services in poorer patients is unclear.
Many of the campaigns to increase the regularity of screen-
ing have dealt with knowledge of and receptivity to screen-
ing. Among low SES women, many of whom lack health
insurance of any sort, cost constraints place screening at a
low priority in comparison with other needs, although recent
inclusion of mammograms under Medicare coverage may
improve this problem in the elderly. Nevertheless the fact
that such a large proportion of women delay for more than 1
month after they notice symptoms, suggests that great imp-
rovements in survival are possible through educational prog-
rams for minority women.
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